NCT02449512

Brief Summary

Spinal cord injury and other systemic neurological diseases (Multiple Sclerosis, Parkinson's disease) affect the integrity of lower urinary tract (LUT) function, leading to neurogenic lower urinary tract dysfunction (NLUTD). The urodynamic investigation is the current "gold-standard" for evaluating LUT function. Nevertheless, the sensory situation of the LUT cannot be investigated objectively. Furthermore, the current classification of the severity of the NLUTD due to spinal cord injury (SCI) does not represent the sensory situation of the LUT. Additional investigations therefore need to be established for assessing the sensory situation of the LUT. Somatosensory evoked potentials (SEPs) are an established method for investigating the processing of sensory nervous activity. However, SEPs from the LUT of SCI individuals have not yet been investigated. A novel technique, i.e. diffusion tensor imaging (DTI), allows to process magnetic resonance images (MRI) in order to visualize nerve fibers. Using DTI, the innervation of the bladder after SCI can be visualized. The structural presentation of bladder innervation will be compared with the functional results, i.e. the SEP of the LUT in SCI individuals. The primary objective of the proposed study is to elicit and characterize (latency, amplitude) the somatosensory evoked potentials (SEPs) from the bladder in individuals suffering from neurogenic lower urinary tract dysfunction as a result of spinal cord injury. Furthermore, the SEPs from the bladder will be compared with the SEPs from peripheral nerves (N. tibialis, N. pudendus, N. medianus). Moreover, the latency and amplitude of the SEPs from the bladder of individuals with somato-sensory complete spinal cord injury will be compared with those from the bladder of individuals with somato-sensory incomplete spinal cord injury. Finally, the structural innervation of the bladder after SCI will be compared with the remaining sensory function.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
32mo left

Started Jan 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2026Dec 2028

First Submitted

Initial submission to the registry

May 15, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 20, 2015

Completed
10.6 years until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

2.4 years

First QC Date

May 15, 2015

Last Update Submit

July 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • occurrence of somatosensory evoked potentials from the bladder

    within 1 week after enrollment into study

Secondary Outcomes (5)

  • latency of somatosensory evoked potentials

    within 1 week after enrollment into study

  • peak-to-peak amplitude of somatosensory evoked potentials

    within 1 week after enrollment into study

  • nerve fiber density around bladder

    within 1 week after enrollment into study

  • fractional anisotropy of nerve fibers around bladder

    within 1 week after enrollment into study

  • apparent diffusion coefficient of nerve fibers around bladder

    within 1 week after enrollment into study

Other Outcomes (3)

  • age

    1st day

  • gender

    1st day

  • severity of spinal cord injury

    1st day

Study Arms (2)

complete

individuals with somato-sensory complete spinal cord injury

incomplete

individuals with somato-sensory incomplete spinal cord injury

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

individuals with neurogenic lower urinary tract dysfunction as a result of spinal cord injury

You may qualify if:

  • Informed Consent as documented by signature
  • Chronic SCI of a minimum of 1 year
  • Aetiology of SCI: traumatic

You may not qualify if:

  • Age \< 18 years or \> 70 years
  • Aetiology of SCI: non-traumatic
  • History of bleeding disorder
  • History of chronic neuropathic pain
  • Intravesical botulinum toxin injections \< 12 months ago
  • Bladder management using indwelling catheters (suprapubic, transurethral)
  • Bladder augmentation
  • Sacral deafferentation
  • Sacral neuromodulation
  • Acute, symptomatic urinary tract infection
  • Pregnancy
  • Urolithiasis
  • Bladder cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Swiss Paraplegic Centre

Nottwil, Canton of Lucerne, CH-6207, Switzerland

Location

Study Officials

  • Jens Wöllner

    Swiss Paraplegic Centre

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2015

First Posted

May 20, 2015

Study Start

January 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations